Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3459786 | 0.88 | CYP1A2 (0.65) | CYP2C9CYP1A2CYP2D6ALDH1A1GAA | |
| SCHEMBL9377030 | 0.84 | CYP1A2 (0.67) | CYP2C9CYP1A2KDM1ADRD1 | |
| P-Xylene SCHEMBL3752326 | 0.82 | CYP1A2 (0.70) | CYP2C9CYP1A2ALDH1A1TSHRPOLB | |
| SCHEMBL475391 | 0.81 | CYP2C9 (0.49) | CYP2C9CYP1A2CYP2D6ALDH1A1USP30 | |
| SCHEMBL335423 | 0.78 | CYP1A2 (0.63) | CYP2C9CYP1A2ALDH1A1MEN1KMT2A | |
| SCHEMBL17781744 | 0.78 | CYP2C9 (0.42) | CYP2C9CYP1A2CYP2D6ALDH1A1USP30 | |
| SCHEMBL10387619 | 0.77 | CYP1A2 (0.61) | CYP2C9CYP1A2CYP2D6ALDH1A1TSHR | |
| SCHEMBL9194077 | 0.77 | CYP1A2 (0.61) | CYP2C9CYP1A2ALDH1A1MEN1KMT2A | |
| SCHEMBL335424 | 0.77 | CYP1A2 (0.61) | CYP2C9CYP1A2CYP2D6ALDH1A1GAA | |
| SCHEMBL9806106 | 0.77 | CYP1A2 (0.61) | CYP2C9CYP1A2ALDH1A1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0535548-B1 | Inhibitor of atherosclerotic intimal thickening | NISSAN CHEMICAL IND LTD (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-6162798-A | Inhibitor of atherosclerotic intimal thickening | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2000-12-19 | — | — | US | disclosed |
| EP-0367235-B1 | Thienopyridine type mevalonolactones | NISSAN CHEMICAL IND LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0535548-A1 | Inhibitor of atherosclerotic intimal thickening | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-07 | — | — | EP | disclosed |
| US-5026698-A | For reducing hyperlipidemia, hyperlipoproteinemia and atheroscierosis | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1991-06-25 | — | — | US | disclosed |
| US-5024999-A | Anti-hyperlipidemia, anti-atherosclerosis agents | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1991-06-18 | — | — | US | disclosed |
| EP-0367235-A1 | Thienopyridine type mevalonolactones | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1990-05-09 | — | — | EP | disclosed |
| EP-0339358-A1 | Pyrazolopyridine type mevalonolactones | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-11-02 | — | — | EP | disclosed |